Taiwan FDA registration c6f9b9a04cd225a0601ae161bf005f25

"Piti" FMC7 reagent

TW: "必帝" FMC7 試劑

Taiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Apr 12, 2006 – Apr 12, 2011Cancelled

Registration details

Analysis ID: c6f9b9a04cd225a0601ae161bf005f25
Customs Code: DHA00601634007

Company information

Manufacturer: BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: Taiwan Branch of American Business Bidi Co., Ltd

Product details

Intended Use: FMC7 recognizes glycoprotein antigens (105 thousand tracts of eutophaus) on some lymphocyte B complexes.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.4020 Analysis of specific tests
Import Information: import

Dates and status

Registration Date: Apr 12, 2006
Expiry Date: Apr 12, 2011
Cancellation Date: Oct 26, 2012

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Piti" FMC7 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c6f9b9a04cd225a0601ae161bf005f25 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.